Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Afag Asgarova"'
Autor:
Masae Kishi, Afag Asgarova, Christophe Desterke, Diana Chaker, Jérôme Artus, Ali G. Turhan, Annelise Bennaceur-Griscelli, Frank Griscelli
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Cancer is maintained by the activity of a rare population of self-renewing “cancer stem cells” (CSCs), which are resistant to conventional therapies. CSCs over-express several proteins shared with induced pluripotent stem cells (iPSCs). We show h
Externí odkaz:
https://doaj.org/article/33669e9b4aa84fc984d4c9b9ffea9672
Autor:
Sandrine Dulong, Lucas Eduardo Botelho de Souza, Jean Machowiak, Benoit Peuteman, Gaelle Duvallet, Déborah Boyenval, Elise Roth, Afag Asgarova, Yunhua Chang, Xiao-Mei Li, Adlen Foudi, Annabelle Ballesta
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2465 (2022)
Oxaliplatin was nearly twice as hematotoxic, with optimal circadian timing differing by 6 h, in women as compared to men with colorectal cancers. Hence, we investigated sex- and timing-related determinants of oxaliplatin hematopoietic toxicities in m
Externí odkaz:
https://doaj.org/article/4eb1871dcdec473f9e2220ee8b078af6
Autor:
Adam Ceroi, Fanny Angelot Delettre, Charline Marotel, Thierry Gauthier, Afag Asgarova, Sabéha Biichlé, Anne Duperrier, Guillaume Mourey, Sylvain Perruche, Laurent Lagrost, David Masson, Philippe Saas
Publikováno v:
Haematologica, Vol 101, Iss 3 (2016)
Externí odkaz:
https://doaj.org/article/bf9da1da17fd4e3caaf79bcc083d9cf7
Autor:
Marie-Ghislaine de Goër de Herve, Ali G. Turhan, Afag Asgarova, Diana Chaker, Masae Heront-Kishi, Annelise Bennaceur-Griscelli, Frank Griscelli, Christophe Desterke
Cancer is maintained by the activity of a rare population of self-renewing “cancer stem cells” (CSCs), which are resistant to conventional therapies. CSCs share several antigenic determinants with pluripotent stem cells (PSCs). We show here that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::608ea3e06a064a2cc3de19701a8f316f
https://doi.org/10.1101/2020.05.27.118471
https://doi.org/10.1101/2020.05.27.118471
Autor:
Elodie Lauret Marie Joseph, Séverine Valmary-Degano, Romain Boidot, Jean-René Pallandre, Olivier Adotevi, Yann Godet, Mohamad Hamieh, Jean Baptiste Latouche, Christophe Borg, Talal Al Saati, Jeanne Galaine, L. Rangan, Afag Asgarova, Laurent Beziaud, Magalie Dosset, Julie Francoual
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2017, 8 (30), pp.48959-48971. ⟨10.18632/oncotarget.16900⟩
Oncotarget, 2017, 8 (30), pp.48959-48971. ⟨10.18632/oncotarget.16900⟩
Oncotarget, Impact journals, 2017, 8 (30), pp.48959-48971. 〈http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path=16900&pubmed-linkout=1〉. 〈10.18632/oncotarget.16900〉
Oncotarget, Impact journals, 2017, 8 (30), pp.48959-48971. ⟨10.18632/oncotarget.16900⟩
Oncotarget, 2017, 8 (30), pp.48959-48971. ⟨10.18632/oncotarget.16900⟩
Oncotarget, Impact journals, 2017, 8 (30), pp.48959-48971. 〈http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path=16900&pubmed-linkout=1〉. 〈10.18632/oncotarget.16900〉
IF 5.168; International audience; HLA-A*0201/DRB1*0101 transgenic mice (A2/DR1 mice) have been developed to study the immunogenicity of tumor antigen-derived T cell epitopes. To extend the use and application of this mouse model in the field of antit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb98cb97c189b51636ddc05b8ae94730
https://doi.org/10.18632/oncotarget.16900
https://doi.org/10.18632/oncotarget.16900
Autor:
Noufissa Oudrhiri, Christophe Desterke, Fatima Dkhissi, Lucie Portier, Ali G. Turhan, Frank Griscelli, Annelise Bennaceur-Griscelli, Diana Chaker, Afag Asgarova
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 3
International Journal of Molecular Sciences, 2021, 22 (3), pp.1227. ⟨10.3390/ijms22031227⟩
International Journal of Molecular Sciences, Vol 22, Iss 1227, p 1227 (2021)
Volume 22
Issue 3
International Journal of Molecular Sciences, 2021, 22 (3), pp.1227. ⟨10.3390/ijms22031227⟩
International Journal of Molecular Sciences, Vol 22, Iss 1227, p 1227 (2021)
Tumor progression begins when cancer cells recruit tumor-associated stromal cells to produce a vascular niche, ultimately resulting in uncontrolled growth, invasion, and metastasis. It is poorly understood, though, how this process might be affected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::180a5945481d85a8e10b0fee2917d4ed
https://doi.org/10.3390/ijms22031227
https://doi.org/10.3390/ijms22031227
Autor:
Elizabeth Macintyre, Jean-Paul Remy-Martin, Anne Roggy, Philippe Saas, Sabeha Biichle, Fanny Angelot-Delettre, David Masson, Francis Bonnefoy, Francine Garnache-Ottou, Cécile Chagué, Afag Asgarova, Laurent Lagrost, Adam Ceroi, Claude Preudhomme, Christophe Roumier, Laure Philippe
Publikováno v:
ResearcherID
Introduction: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy derived from plasmacytoid dendritic cells (pDC). Today, no therapeutic consensus exists and only allogeneic hematopoietic cell transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::151db7d777d9b89d60261fae77f573d5
https://doi.org/10.1182/blood.v126.23.4933.4933
https://doi.org/10.1182/blood.v126.23.4933.4933